Ixekizumab: targeting plaque psoriasis and psoriatic arthritis

Ixekizumab (Taltz) is an anti-interleukin-17A monoclonal antibody therapy for the treatment of adults with plaque psoriasis or psoriatic arthritis. This article discusses its efficacy and place in therapy.

Read the full article.

Add yours ↓
Web design and marketing agency Leamington Spa